Literature DB >> 18523298

Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.

Colin Reardon1, Arthur Wang, Derek M McKay.   

Abstract

Regulatory T cells (Tregs) play a fundamental role in regulating the immune system in health and disease. Considerable evidence exists demonstrating that transfer of Tregs can cure colitis and a variety of other inflammatory disorders. However, little is known about the effects of inflammation on resident Tregs. Mice (BALB/c or C57BL/6) treated with an intrarectal instillation of the haptenizing agent 2,4-dinitrobenzene sulfonic acid (DNBS) develop an acute inflammatory disease, the histopathology of which peaks at 3 days posttreatment and resolves spontaneously thereafter. In this study we demonstrate that DNBS (or oxazolone)-induced colitis causes a depletion of colonic Foxp3+ Tregs 8 days posttreatment, while the proportion of Foxp3+ cells in the ileum, mesenteric lymph nodes, and spleen remains unchanged. Replenishment of the colonic Treg population was associated with the reappearance of mucosal homing (alpha4beta7+) CD4+Foxp3+ Tregs. Assessing the mechanism of local Treg depletion, we found no evidence to implicate cytokine-induced phenotypic switching in the Foxp3+ population or increased SMAD7 expression despite the essential role that TGF-beta has in Foxp3+ Treg biology. Increased Fas ligand (FasL) expression was observed in the colon of colitic mice and in vitro stimulation with a Fas cross-linking Ab resulted in apoptosis of CD4+Foxp3+ but not CD4+Foxp3- cells. Furthermore, DNBS-induced colitis in Fas/FasL-deficient mice did not result in depletion of colonic Tregs. Finally, adoptively transferred synergic Fas-/- but not Fas+/+ Tregs were protected from depletion in the colon 8 days post-DNBS treatment, thus substantiating the hypothesis that inflammation-induced local depletion of Foxp3+ Tregs in the colon of mice occurs via Fas/FasL-mediated death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523298     DOI: 10.4049/jimmunol.180.12.8316

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.

Authors:  Esma S Yolcu; Hong Zhao; Laura Bandura-Morgan; Chantale Lacelle; Kyle B Woodward; Nadir Askenasy; Haval Shirwan
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

2.  Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils.

Authors:  Arthur Wang; Maria Fernando; Gabriella Leung; Van Phan; David Smyth; Derek M McKay
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

Review 3.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

4.  The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.

Authors:  Meher K Rahman; Emilie H Midtling; Phyllis A Svingen; Yuning Xiong; Michael P Bell; Jeanne Tung; Tom Smyrk; Larry J Egan; William A Faubion
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

Review 5.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response.

Authors:  Richard J Betts; Nayana Prabhu; Adrian W S Ho; Fei Chuin Lew; Paul E Hutchinson; Olaf Rotzschke; Paul A Macary; D Michael Kemeny
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

7.  Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells.

Authors:  Yifan Zhan; Yuxia Zhang; Daniel Gray; Emma M Carrington; Philippe Bouillet; Hyun-Ja Ko; Lorraine O'Reilly; Ian P Wicks; Andreas Strasser; Andrew M Lew
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

8.  A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes.

Authors:  Gisen Kim; Ryo Shinnakasu; Christiaan J M Saris; Hilde Cheroutre; Mitchell Kronenberg
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

9.  Soluble CD83 ameliorates experimental colitis in mice.

Authors:  J Eckhardt; S Kreiser; M Döbbeler; C Nicolette; M A DeBenedette; I Y Tcherepanova; C Ostalecki; A J Pommer; C Becker; C Günther; E Zinser; T W Mak; A Steinkasserer; M Lechmann
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

10.  Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.

Authors:  Rebecca M Tucker; Amy G Feldman; Erika K Fenner; Cara L Mack
Journal:  J Hepatol       Date:  2013-05-14       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.